Navigation Links
Nasdaq Informs Synutra that the Company's Filing Delinquency has been Cured
Date:10/11/2007

QINGDAO, China and ROCKVILLE, Md., Oct. 11 /Xinhua-PRNewswire/ -- On October 10, 2007, Synutra International, Inc. (Nasdaq: SYUT; "Synutra"), one of China's leading manufacturers of dairy-based nutritional products for infants, children and adults, received a letter from the Nasdaq Stock Market stating that the Company's common stock is no longer subject to delisting following the filing with the SEC on October 5, 2007 of the Company's quarterly report on Form 10-Q for the period ended June 30, 2007. Upon review of the filing, the Nasdaq staff determined that Synutra meets all listing criteria and is in compliance with Nasdaq Marketplace Rule 4310(c)(14), which states that timely filing of annual and periodic reports with the SEC is required for continued listing. Accordingly, the Company's scheduled hearing before Nasdaq's Listing Qualifications Panel has been considered moot.

About Synutra International, Inc.

Synutra operates eight subsidiaries developing, producing, distributing and selling dairy-based nutritional products across the People's Republic of China. It offers its products for infants, children, adults and pregnant women and nursing mothers under the brand series of "Super," "U-Smart" and "U- Strong." The Group's extensive sales network covers 24 provinces, 264 cities and more than 1320 counties throughout China. For more information, please contact Weiguo Zhang of Synutra, Inc. (+1-301-840-3888, wzhang@synutra.com), Brian Rafferty of Taylor Rafferty (+1-212-889-4350, synutra@taylor-rafferty.com) or visit: http://www.synutra.com.

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward- looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

For more information, please contact:

Mr. Weiguo Zhang, Synutra, Inc.

Phone: +1-301-840-3888

Email: wzhang@synutra.com

Mr. Brian Rafferty

Taylor Rafferty

Phone: +1-212-889-4350

Email: synutra@taylor-rafferty.com


'/>"/>
SOURCE Synutra International, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Patna To Receive Better Health Care Facility Informs Health Minister
2. Nutrient Profiling System Launched By Food Officials in UK
3. Proteomic Profiling Can Detect Preterm Birth Risk
4. Brains Filing System Uncovered
5. Profiling of Cancer Genes May Lead to Earlier Detection Human Cancers
6. Sweaty palms syndrome can be cured by surgery
7. Muscular Dystrophy May Be Cured By Gene Therapy
8. Back injury cured by engineers
9. Multiple organ disease cured by genes
10. Hay fever may be cured by self-hypnosis
11. Women cured of anorexia nervosa have redistributed body fat after weight gain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, a ... Miami, and Raleigh regions, is organizing an extended charity drive to benefit the ... chromosome abnormality. , After struggling since birth with several health challenges, T.J. was ...
(Date:10/13/2017)... Pekin, IL (PRWEB) , ... October 13, 2017 ... ... Foundation, which established the certification process to promote standards of excellence for the ... iaedp™ Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at ...
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... Oct. 4, 2017  South Korean-based healthcare product Development ... aide "cprCUBE" on Kickstarter. The device will educate the ... arrests with better efficiency compared to the dated and ... feedback on efficacy of the compression for a more ... a goal to raise $5,000. ...
(Date:10/2/2017)... FLINT, Mich. , Oct. 2, 2017 ... acquired 8th Day Software and Consulting, LLC , ... 8th Day Software, based in Tennessee ... Management LLC. 8th Day expands EnvoyHealth,s service offerings for ... product development. "In ...
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
Breaking Medicine Technology: